Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Haynie

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Drug Discovery Today|March 9, 2024
Rise of the Allotrope Simple Model: Update from 2023 Fall Allotrope ConnectSpencer Gardiner, Christopher Haynie, Dennis Della Corte
Biomedicines|July 27, 2022
Alternative CAR Therapies: Recent Approaches in Engineering Chimeric Antigen Receptor Immune Cells to Combat CancerCarlos Moreno, Christopher Haynie, Abigail Cheever, et al.
International Journal of Molecular Sciences|November 25, 2023
The Role of Atypical Chemokine Receptors in Neuroinflammation and Neurodegenerative DisordersHunter G Lindsay, Colby J Hendrix, Josue D Gonzalez Murcia, et al.
Biomedicines|March 25, 2022
CD5 Deficiency Alters Helper T Cell Metabolic Function and Shifts the Systemic MetabolomeKiara V Whitley, Claudia M Tellez Freitas, Carlos Moreno, et al.
ACS Catalysis|February 12, 2026
Advancing NanoLuc Luciferase Stability beyond Directed Evolution and Rational Design through Expert-Guided Deep LearningSpencer Gardiner, Joseph Talley, Tyler Green, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Advancing Luciferase Activity and Stability beyond Directed Evolution and Rational Design through Expert Guided Deep LearningSpencer Gardiner, Joseph Talley, Christopher Haynie, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Drug Discovery Today|March 9, 2024
Rise of the Allotrope Simple Model: Update from 2023 Fall Allotrope ConnectSpencer Gardiner, Christopher Haynie, Dennis Della Corte
Biomedicines|July 27, 2022
Alternative CAR Therapies: Recent Approaches in Engineering Chimeric Antigen Receptor Immune Cells to Combat CancerCarlos Moreno, Christopher Haynie, Abigail Cheever, et al.
International Journal of Molecular Sciences|November 25, 2023
The Role of Atypical Chemokine Receptors in Neuroinflammation and Neurodegenerative DisordersHunter G Lindsay, Colby J Hendrix, Josue D Gonzalez Murcia, et al.
Biomedicines|March 25, 2022
CD5 Deficiency Alters Helper T Cell Metabolic Function and Shifts the Systemic MetabolomeKiara V Whitley, Claudia M Tellez Freitas, Carlos Moreno, et al.
ACS Catalysis|February 12, 2026
Advancing NanoLuc Luciferase Stability beyond Directed Evolution and Rational Design through Expert-Guided Deep LearningSpencer Gardiner, Joseph Talley, Tyler Green, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Advancing Luciferase Activity and Stability beyond Directed Evolution and Rational Design through Expert Guided Deep LearningSpencer Gardiner, Joseph Talley, Christopher Haynie, et al.
Pageof 1